申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:EP0706994A1
公开(公告)日:1996-04-17
New melatonergic agents are phenyl alkanyl or phenyl alkyl substituted carboxamides and ureas of Formula I:
wherein:
R₁ = C₁₋₃ alkyl, allyl, C₃₋₆ cycloalkyl substituted C₁₋₄ alkyl;
R₂ = hydrogen, halogen or C₁₋₄ alkoxy;
R₃ = hydrogen or C₁₋₄ alkyl;
R₄ = C₁₋₄ alkyl, C₁₋₄ alkyl substituted amino, carboxylic acid substituted C₁₋₄ alkyl or C₃₋₆ cycloalkyl, C₁₋₄ alkoxy substituted C₁₋₄ alkyl, C₃₋₆ cycloalkyl, or straight or branched chain C₂₋₄ alkenyl;
A = a linear C₂₋₄ alkanediyl or alkenediyl chain, provided that A not be -CH₂CH₂- when X is a bond; and
X = a covalent bond or oxygen.
新的褪黑激素制剂是式 I 的苯基烷基或苯基烷基取代的羧酰胺和脲:
其中
R₁ = C₁₋₃ 烷基、烯丙基、C₃₋₆ 环烷基取代的 C₁₋₄ 烷基;
R₂ = 氢、卤素或 C₁₋₄ 烷氧基;
R₃ = 氢或 C₁₋₄ 烷基;
R₄ = C₁₋₄ 烷基、C₁₋₄ 烷基取代的氨基、羧酸取代的 C₁₋₄ 烷基或 C₃₋₆ 环烷基、C₁₋₄ 烷氧基取代的 C₁₋₄ 烷基、C₃₋₆ 环烷基或直链或支链 C₂₋₄ 烯基;
A = 直链 C₂₋₄烷二基或烯二基,但当 X 为键时,A 不得为-CH₂CH₂-;以及
X = 共价键或氧。